Intraocular Pressure

Switching patients to an interventional glaucoma treatment paradigm offers benefits, but ophthalmologists must be aware of how to effectively minimize drawbacks, according to a presentation at Real World Ophthalmology.

In the cover story of this issue of Healio | OSN, we explore trabeculectomy as a time-honored glaucoma procedure.

MARCO ISLAND, Fla. — Two-year follow-up of the ROMEO study showed efficacy of the Omni surgical system in reducing IOP and medication use over the long term in patients with primary open-angle glaucoma.

Differences in IOP values and biomechanical parameters between the first and second eye measured, as well as by device used, were significant but not likely to affect outcomes in clinical or research settings, according to study results.

SEATTLE — A laboratory study showed significant variation in accuracy and residual volume among syringes commonly used for intravitreal injections and evaluated the risk for high IOP elevation with higher than anticipated fluid volumes.

Differential IOP phacoemulsification is a new concept from Rohit Om Parkash, MBBS, MS, and a video on the topic won the film festival award at this year’s American Society of Cataract and Refractive Surgery meeting.

KIAWAH ISLAND, S.C. — In this presentation from Kiawah Eye, Leon W. Herndon Jr., MD, explores the future of sustained-release drug delivery for glaucoma treatment, which may help improve patient compliance.

Visiox Pharma has entered into a definitive agreement with Santen Pharmaceutical to license product manufacturing and commercialization rights for Omlonti in the U.S., according to a press release.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Reay H. Brown, MD, discusses the Omni Ergo-Series and Sion surgical instrument from Sight Sciences.

At the 2023 American Glaucoma Society annual meeting, my colleagues and I shared the findings of a study on IOP follow-up and prostaglandin analog therapy.